Used properly, sanctions can immobilize assets, exclude suspected criminals from the financial system, and disrupt international networks – but what about delivering justice?
China
Analysing the compliance imperatives for both US pharma and the strategic considerations for Chinese biotech navigating the cross-border environment.
Our regular look at notable regulatory and compliance developments in the region.
Several legislative proposals, actions, and regulations are underway in parallel, all at different stages of maturity and all subject to significant political uncertainty.
Panel discussion featured senior figures from financial centers in New York, London, Shanghai, Paris, and Riyadh.
The judgment sends a powerful message about the limits of deceit in heavily negotiated M&A transactions and the high threshold for these types of claims.
For MNCs, these regulations expand scrutiny beyond foreign government actions to include commercial activities that threaten supply-chain stability.
Our March 2026 roundup from the financial regulation industries across the Asia-Pacific region.